M. Coppens MD PhD publications

2021

• Schep Sarah J., van Dijk Wobke E. M., Beckers Erik A. M., Meijer Karina, Coppens Michiel, Eikenboom Jeroen, Leebeek Frank W. G., van Vulpen Lize F. D., Fischer Kathelijn F., Schutgens Roger E. G. Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study American journal of hematology 2021;96 (1):51-59 [PubMed]

2020

• Boender Johan, Nederlof Angelique, Meijer Karina, Mauser-Bunschoten Evelien P., Cnossen Marjon H., Fijnvandraat Karin, van der Bom Johanna G., de Meris Joke, Laros-van Gorkom Britta A. P., van Galen Karin P. M., Eikenboom Jeroen, de Maat Moniek P. M., Leebeek Frank W. G., Coppens M., Nieuwenhuizen L., Tamminga R. Y. J., Ypma P. F., Smiers F. J. W., Beckers E., Brons P., Atiq F. ADAMTS-13 and bleeding phenotype in von Willebrand disease Research and practice in thrombosis and haemostasis 2020;4 (8):1331-1339 [PubMed]
• Blaauwgeers Maaike W., Kruip Marieke J. H. A., Beckers Erik A. M., Coppens Michiel, Eikenboom Jeroen, van Galen Karin P. M., Tamminga Rienk Y. J., Urbanus Rolf T., Schutgens Roger E. G. Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects American journal of hematology 2020;95 (10):1142-1147 [PubMed]
• Blaauwgeers Maaike W, Kruip Marieke J H A, Beckers Erik A M, Coppens Michiel, Eikenboom Jeroen, van Galen Karin P M, Tamminga Rienk Y J, Urbanus Rolf T, Schutgens Roger E G Congenital platelet disorders and health status-related quality of life Research and practice in thrombosis and haemostasis 2020;4 (1):100-105 [PubMed]
• Bavalia Roisin, Abdoellakhan Rahat, Brinkman Herm Jan M, Brekelmans Marjolein P A, Hamulyák Eva N, Zuurveld Marleen, Hutten Barbara A, Westerweel Peter E, Olie Renske H, Ten Cate Hugo, Kruip Marieke, Middeldorp Saskia, Meijer Karina, Coppens Michiel Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate Research and practice in thrombosis and haemostasis 2020;4 (4):569-581 [PubMed]
• Cohen Alexander T., Hoffmann Ulrich, Hainaut Philippe, Gaine Sean, Ay Cihan, Coppens Michiel, Schindewolf Marc, Jimenez David, Brüggenjürgen Bernd, Levy Pierre, Laeis Petra, Fronk Eva-Maria, Zierhut Wolfgang, Malzer Thomas, Manu Marius Constantin, Reimitz Paul-Egbert, Bramlage Peter, Agnelli Giancarlo ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries European journal of internal medicine 2020;82:48-55 [PubMed]
• Agnelli Giancarlo, Hoffmann Ulrich, Hainaut Philippe, Gaine Sean, Ay Cihan, Coppens Michiel, Schindewolf Marc, Jimenez David, Brüggenjürgen Bernd, Levy Pierre, Laeis Petra, Fronk Eva-Maria, Zierhut Wolfgang, Malzer Thomas, Manu Marius Constantin, Reimitz Paul-Egbert, Bramlage Peter, Cohen Alexander T. ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months Thrombosis research 2020;196:297-304 [PubMed]
• van Asten Ivar, Blaauwgeers Maaike, Granneman Lianne, Heijnen Harry F. G., Kruip Marieke J. H. A., Beckers Erik A. M., Coppens Michiel, Eikenboom Jeroen, Tamminga Rienk Y. J., Pasterkamp Gerard, Huisman Albert, van Galen Karin P. M., Korporaal Suzanne J. A., Schutgens Roger E. G., Urbanus Rolf T. Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency Journal of thrombosis and haemostasis 2020;18 (3):706-713 [PubMed]
• Limperg Perrine F., Maurice-Stam Heleen, Heesterbeek Madelief R., Peters Marjolein, Coppens Michiel, Kruip Marieke J. H. A., Eikenboom Jeroen, Grootenhuis Martha A., Haverman Lotte Illness cognitions associated with health-related quality of life in young adult men with haemophilia Haemophilia 2020;26 (5):793-799 [PubMed]
• Middeldorp Saskia, Coppens Michiel, van Haaps Thijs F., Foppen Merijn, Vlaar Alexander P., Müller Marcella C. A., Bouman Catherine C. S., Beenen Ludo F. M., Kootte Ruud S., Heijmans Jarom, Smits Loek P., Bonta Peter I., van Es Nick Incidence of venous thromboembolism in hospitalized patients with COVID-19 Journal of thrombosis and haemostasis 2020;18 (8):1995-2002 [PubMed]
• Leader Avi, Hamulyák Eva N., Carney Brian J., Avrahami Maya, Knip Jelijn J., Rozenblatt Shira, Beenen Ludo F. M., Yust-Katz Shlomit, Icht Oded, Coppens Michiel, Raanani Pia, Middeldorp Saskia, Büller Harry R., Zwicker Jeffrey I., Spectre Galia Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases Blood advances 2020;4 (24):6291-6297 [PubMed]
• Hassan Shermarke, Monahan Rory C., Mauser-Bunschoten Evelien P., van Vulpen Lize F. D., Eikenboom Jeroen, Beckers Erik A. M., Hooimeijer Louise, Ypma Paula F., Nieuwenhuizen Laurens, Coppens Michiel, Schols Saskia E. M., Leebeek Frank W. G., Smit Cees, Driessens Mariëtte H., le Cessie Saskia, van Balen Erna C., Rosendaal Frits R., van der Bom Johanna G., Gouw Samantha C. Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018 Journal of thrombosis and haemostasis 2020 [PubMed]
• de Jager Nico C. B., Bukkems Laura H., Heijdra Jessica M., Hazendonk Carolien H. C. A. M., Fijnvandraat Karin, Meijer Karina, Eikenboom Jeroen, Laros - van Gorkom Britta A. P., Leebeek Frank W. G., Cnossen Marjon H., Mathôt Ron A. A., Collins P. W., Kruip M. J. H. A., Polinder S., Lock J., van Moort I., Goedhart M. C. H. J., Coppens M., Peters M., Preijers T., Brons P., van der Meer F. J. M., Schutgens R. E. G., Fischer K., Driessens M. H. E., Zwaan C. M., van Vliet I., Liesner R., Chowdary P., Keeling D. One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P®/Humate P® treatment in von Willebrand disease patients Journal of thrombosis and haemostasis 2020;18 (2):295-305 [PubMed]
• Walsh Christopher, Coppens Michiel, Escobar Miguel, Wang Michael Optimal trough levels in haemophilia B: Raising expectations Haemophilia 2020;26 (6):e334-e336 [PubMed]
• Bavalia Roisin, Abdoellakhan Rahat, Beenen Ludo F., Brekelmans M. P. A., Olie Renske H., ten Cate Hugo, Huisman Menno V., Kruip Marieke, Middeldorp Saskia, Meijer Karina, Hutten Barbara A., Coppens Michiel Outcome of intracranial bleeding managed with prothrombin complex concentrate in patients on direct factor Xa inhibitors or vitamin K antagonists Thrombosis research 2020;196:404-409 [PubMed]
• van Balen Erna C., Wesselo Marjolein L., Baker Bridget L., Westerman Marjan J., Coppens Michiel, Smit Cees, Driessens Mariëtte H. E., Leebeek Frank W. G., van der Bom Johanna G., Gouw Samantha C. Patient Perspectives on Novel Treatments in Haemophilia: A Qualitative Study PATIENT-PATIENT CENTERED OUTCOMES RESEARCH 2020;13 (2):201-210 [PubMed]
• Shaw Joseph R., Li Na, Vanassche Thomas, Coppens Michiel, Spyropoulos Alex C., Syed Summer, Radwi Mansoor, Duncan Joanne, Schulman Sam, Douketis James D. Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure Blood advances 2020;4 (15):3520-3527 [PubMed]
• Saes Joline L, Laros-van Gorkom Britta A P, Coppens Michiel, Schols Saskia E M Pregnancy outcome in afibrinogenemia: Are we giving enough fibrinogen concentrate? A case series Research and practice in thrombosis and haemostasis 2020;4 (2):343-346 [PubMed]
• Blaauwgeers Maaike W., van Asten Ivar, Kruip Marieke J. H. A., Beckers Erik A. M., Coppens Michiel, Eikenboom Jeroen, van Galen Karin P. M., Huisman Albert, Korporaal Suzanne J. A., Ploos van Amstel Hans Kristian, Tamminga Rienk Y. J., Urbanus Rolf T., Schutgens Roger E. G. The limitation of genetic testing in diagnosing patients suspected for congenital platelet defects American journal of hematology 2020;95 (1):E26-E28 [PubMed]
• Notten Pascale, ten Cate-Hoek Arina J., Arnoldussen Carsten W. K. P., Strijkers Rob H. W., de Smet André A. E. A., Tick Lidwine W., van de Poel Marlène H. W., Wikkeling Otmar R. M., Vleming Louis-Jean, Koster Ad, Jie Kon-Siong G., Jacobs Esther M. G., Ebben Harm P., Coppens Michiel, Toonder Irwin, ten Cate Hugo, Wittens Cees H. A. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial Lancet. Haematology 2020;7 (1):e40-e49 [PubMed]

2019

• Atiq Ferdows, Fijnvandraat Karin, van Galen Karin P. M., Laros-van Gorkom Britta A. P., Meijer Karina, de Meris Joke, Coppens Michiel, Mauser-Bunschoten Eveline P., Cnossen Marjon H., van der Bom Johanna G., Eikenboom Jeroen, Leebeek Frank W. G., Coppens M., Kors A., Zweegman S., de Meris J., Goverde G. J., Jonkers M. H., Dors N., Nijziel M. R., Nieuwenhuizen L., Meijer K., Tamminga R. Y. J., van der LindenHagaZiekenhuis P. W., Ypma P. F., Eikenboom H. C. J., van der Bom J. G., Smiers F. J. W., Granzen B., Hamulyák K., Brons P., Laros‐van Gorkom B. A. P., Leebeek F. W. G., Cnossen M. H., Atiq F., Mauser-Bunschoten E. P., van Galen K. P. M., Atiq F. BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease American journal of hematology 2019;94 (8):E201-E205 [PubMed]
• Schütte Lisette M., Cnossen Marjon H., van Hest Reinier M., Driessens Mariette H. E., Fijnvandraat Karin, Polinder Suzanne, Beckers Erik A. M., Coppens Michiel, Eikenboom Jeroen, Laros-van Gorkom Britta A. P., Meijer Karina, Nieuwenhuizen Laurens, Mauser-Bunschoten Evelien P., Leebeek Frank W. G., Mathôt Ron A. A., Kruip Marieke J. H. A. Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: Protocol for a multicentre single-armed trial, the DAVID study BMJ open 2019;9 (4) [PubMed]
• Barco Stefano, Granziera Serena, Coppens Michiel, Douxfils Jonathan, Nijkeuter Mathilde, Riva Nicoletta, Vanassche Thomas, Zhang George, Lin Min, Kamphuisen Pieter W, Cohen Alexander T, Beyer-Westendorf Jan Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE Thrombosis and haemostasis 2019;119 (4):675-684 [PubMed]
• Mol G. C. M., Büller H. R., Sinnige H. A. M., Péquériaux N. C. V., Coppens M. Perioperative bridging of anticoagulation: Towards a more reserved approach Netherlands journal of medicine 2019;77 (8):280-286
• Douketis James D, Spyropoulos Alex C, Duncan Joanne, Carrier Marc, Le Gal Gregoire, Tafur Alfonso J, Vanassche Thomas, Verhamme Peter, Shivakumar Sudeep, Gross Peter L, Lee Agnes Y Y, Yeo Erik, Solymoss Susan, Kassis Jeannine, Le Templier Geneviève, Kowalski Stephen, Blostein Mark, Shah Vinay, MacKay Elizabeth, Wu Cynthia, Clark Nathan P, Bates Shannon M, Spencer Frederick A, Arnaoutoglou Eleni, Coppens Michiel, Arnold Donald M, Caprini Joseph A, Li Na, Moffat Karen A, Syed Summer, Schulman Sam Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant JAMA internal medicine 2019;179 (11):1469-1478 [PubMed]
• Limperg Perrine F., Maurice-Stam Heleen, Haverman Lotte, Coppens Michiel, Kruip Marieke J. H. A., Eikenboom Jeroen, Grootenhuis Martha A., Peters Marjolein Professional functioning of young adults with congenital coagulation disorders in the Netherlands Haemophilia 2019;25 (3):e138-e145 [PubMed]
• Escobar Miguel, Santagostino Elena, Mancuso Maria Elisa, Coppens Michiel, Balasa Vinod, Taylor Jason A, Iorio Alfonso, Negrier Claude Switching patients in the age of long-acting recombinant products? Expert review of hematology 2019;12 (sup1):1-13 [PubMed]
• Coppens Michiel, Weitz Jeffrey I, Eikelboom John W A Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease Circulation research 2019;124 (3):416-425 [PubMed]

2018

• Cohen Alexander T., Ay Cihan, Hainaut Philippe, Décousus Hervé, Hoffmann Ulrich, Gaine Sean, Coppens Michiel, da Silva Pedro Marques, Jimenez David, Amann-Vesti Beatrice, Brüggenjürgen Bernd, Levy Pierre, Bastida Julio Lopez, Vicaut Eric, Laeis Petra, Fronk Eva-Maria, Zierhut Wolfgang, Malzer Thomas, Bramlage Peter, Agnelli Giancarlo Correction: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study [Thrombosis Journal, 16, (2018) (9)] DOI: 10.1186/s12959-018-0163-7 Thrombosis journal 2018;16 (1) [PubMed]
• Cohen Alexander T., Ay Cihan, Hainaut Philippe, Décousus Hervé, Hoffmann Ulrich, Gaine Sean, Coppens Michiel, da Silva Pedro Marques, Castro David Jimenez, Amann-Vesti Beatrice, Brüggenjürgen Bernd, Levy Pierre, Bastida Julio Lopez, Vicaut Eric, Laeis Petra, Fronk Eva-Maria, Zierhut Wolfgang, Malzer Thomas, Bramlage Peter, Agnelli Giancarlo Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study Thrombosis journal 2018;16 (1) [PubMed]
• Douketis James D., Spyropoulos Alex C., Anderson Julia M., Arnold Donald M., Bates Shannon M., Blostein Mark, Carrier Marc, Caprini Joseph A., Clark Nathan P., Coppens Michiel, Dentali Francesco, Duncan Joanne, Gross Peter L., Kassis Jeannine, Kowalski Stephen, Lee Agnes Y., Gal Gregoire Le, Templier Geneviève Le, Li Na, Mackay Elizabeth, Shah Vinay, Shivakumar Sudeep, Solymoss Susan, Spencer Frederick A., Syed Summer, Tafur Alfonso J., Vanassche Thomas, Thiele Thomas, Wu Cynthia, Yeo Erik, Schulman Sam Erratum: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale (Thromb Haemost (2017) 117 (2415-2424) DOI: 10.1160/TH17-08-0553) Thrombosis and haemostasis 2018;118 (9):1679-1680 [PubMed]
• Miesbach Wolfgang, Meijer Karina, Coppens Michiel, Kampmann Peter, Klamroth Robert, Schutgens Roger, Tangelder Marco, Castaman Giancarlo, Schwäble Joachim, Bonig Halvard, Seifried Erhard, Cattaneo Federica, Meyer Christian, Leebeek Frank W. G. Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B Blood 2018;131 (9) [PubMed]
• Moesker M. J., Damen N. L., Volmeijer E. E., Dreesens D., de Loos E. M., Vink R., Coppens M., Kruip M. J., Meijer K., Langelaan M., de Bruijne M. C., Wagner C. Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal Thrombosis research 2018;168:5-13 [PubMed]
• Limperg P. F., Haverman L., Maurice-Stam H., Coppens M., Valk C., Kruip M. J. H. A., Eikenboom J., Peters M., Grootenhuis M. A. Health-related quality of life, developmental milestones, and self-esteem in young adults with bleeding disorders Quality of life research 2018;27 (1):159-171 [PubMed]
• Scheres Luuk J J, Lijfering Willem M, Middeldorp Saskia, Cheung Yuk W, Barco Stefano, Cannegieter Suzanne C, Coppens Michiel Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials Research and practice in thrombosis and haemostasis 2018;2 (4):689-695 [PubMed]
• Zwagemaker A., Gouw S. C., Valk C., Ganzevoort W., Coppens M., Peters M. Postpartum haemorrhage in an unselected cohort of carriers of haemophilia Haemophilia 2018;24 (4):e256-e259 [PubMed]
• Brekelmans Marjolein P. A. Treatment of venous thromboembolism: focus on patient characteristics and bleeding complications 2018. ISBN 9789462999084. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Middeldorp S.; Co-supervisors: Coppens M., Hutten B. A.)

2017

• Barco Stefano, Atema Jasper J., Coppens Michiel, Serlie Mireille J., Middeldorp Saskia Anticoagulants for the prevention and treatment of catheter-related thrombosis in adults and children on parenteral nutrition: a systematic review and critical appraisal Blood transfusion 2017;15 (4):369-377 [PubMed]
• Brekelmans Marjolein P. A., Ginkel Kim van, Daams Joost G., Hutten Barbara A., Middeldorp Saskia, Coppens Michiel Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis Journal of thrombosis and thrombolysis 2017;44 (1):118-129 [PubMed]
• Kool Remi O., Kohler Hans P., Coutinho Jonathan M., Levi Marcel, Coppens Michiel, Meijers Joost C. M., Schroeder Verena Coagulation factor XIII-A subunit and activation peptide levels in individuals with established symptomatic acute deep vein thrombosis Thrombosis research 2017;159:96-99 [PubMed]
• van Spall Harriette G. C., Rahman Tahseen, Mytton Oliver, Ramasundarahettige Chinthanie, Ibrahim Quazi, Kabali Conrad, Coppens Michiel, Brian Haynes R., Connolly Stuart Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis European journal of heart failure 2017;19 (11):1427-1443 [PubMed]
• Lauw Mandy N., Eikelboom John W., Coppens Michiel, Wallentin Lars, Yusuf Salim, Ezekowitz Michael, Oldgren Jonas, Nakamya Juliet, Wang Jia, Connolly Stuart J. Effects of dabigatran according to age in atrial fibrillation Heart (British Cardiac Society) 2017;103 (13):1015-1023 [PubMed]
• Cheung Y. Whitney, Barco Stefano, Mathôt Ron A. A., van den Dool Erik-Jan, Stroobants An K., Serlie Mireille J., Middeldorp Saskia, Coppens Michiel Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study Thrombosis research 2017;160:76-82 [PubMed]
• Abdul S., Boender J., Malfliet J. J. M. C., Eikenboom J., Fijn van Draat K., Mauser-Bunschoten E. P., Meijer K., de Meris J., Laros-van Gorkom B. A. P., van der Bom J. G., Leebeek F. W. G., Rijken D. C., Uitte de Willige S., Coppens M., Kors A., Jonkers H., Boersma R., Beckers A., Granzen B., Tamminga J., der Linden W., Ypma F., Smiers W., Brons P., Nijziel M., Cnossen H. Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease Haemophilia 2017;23 (3):437-443 [PubMed]
• Brekelmans M. P. A., Kappelhof M., Nieuwkerk P. T., Nierman M., Buller H. R., Coppens M. Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism Netherlands journal of medicine 2017;75 (2):50-55 [PubMed]
• Müller Marcella C. A., Stanworth Simon J., Coppens Michiel, Juffermans Nicole P. Recognition and Management of Hemostatic Disorders in Critically Ill Patients Needing to Undergo an Invasive Procedure Transfusion medicine reviews 2017;31 (4):223-229 [PubMed]
• Barco Stefano, Picchi Chiara, Trinchero Alice, Middeldorp Saskia, Coppens Michiel Safety of prothrombin complex concentrate in healthy subjects British journal of haematology 2017;176 (4):664-666 [PubMed]
• Douketis James D., Spyropoulos Alex C., Anderson Julia M., Arnold Donald M., Bates Shannon M., Blostein Mark, Carrier Marc, Caprini Joseph A., Clark Nathan P., Coppens Michiel, Dentali Francesco, Duncan Joanne, Gross Peter L., Kassis Jeannine, Kowalski Stephen, Lee Agnes Y., Le Gal Gregoire, Le Templier Geneviève, Li Na, MacKay Elizabeth, Shah Vinay, Shivakumar Sudeep, Solymoss Susan, Spencer Frederick A., Syed Summer, Tafur Alfonso J., Vanassche Thomas, Thiele Thomas, Wu Cynthia, Yeo Erik, Schulman Sam The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale Thrombosis and haemostasis 2017;117 (12):2415-2424 [PubMed]
• Coppens M. What can we learn from real world studies on direct oral anticoagulants? Netherlands heart journal 2017;25 (10):545-550 [PubMed]

2016

• Connolly Stuart J., Milling Truman J., Eikelboom John W., Gibson C. Michael, Curnutte John T., Gold Alex, Bronson Michele D., Lu Genmin, Conley Pamela B., Verhamme Peter, Schmidt Jeannot, Middeldorp Saskia, Cohen Alexander T., Beyer-Westendorf Jan, Albaladejo Pierre, Lopez-Sendon Jose, Goodman Shelly, Leeds Janet, Wiens Brian L., Siegal Deborah M., Zotova Elena, Meeks Brandi, Nakamya Juliet, Lim W. Ting, Crowther Mark, Connolly S. C., Crowther M., Eikelboom J., Gibson M., Milling T. J., Albaladejo P., Cohen A., Lopez-Sendon J., Schmidt J., Verhamme P., Beyer-Westendorf J., Wyse D. G., Garcia D., Prins M. [=Martin H.], Nakamya J., Büller H. R., Mahaffey K., Alexander J., Demchuk A., Raskob G., Schulman S., Meeks B., Zotova E., Holadyk-Gris I., Coppens M. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors New England journal of medicine 2016;375 (12):1131-1141 [PubMed]
• Cheung Yuk Wah Diagnosis, treatment and long-term effects of venous thromboembolism 2016. 265p. ISBN 9789402803761. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Middeldorp S.; Co-supervisors: ten Wolde M., Coppens M.)
• Lock J., de Bekker-Grob E. W., Urhan G., Peters M., Meijer K., Brons P., van der Meer F. J. M., Driessens M. H. E., Collins P. W., Fijnvandraat K., Leebeek F. W. G., Cnossen M. H., Mathôt R. A. A., Kruip M. H., de Wildt S. N., Polinder S., Ista W. G., Hazendonk H. C. A. M., van Moort I., Steyerberg E. W., Borsboom G. J. J. M., Preijers T., Stokhuijzen E., Coppens M., Middeldorp S., Tamminga R. Y. J., Laros-van Gorkom B. A. P., Eikenboom H. C. J., Schutgens R. E. G., de Meris J., Zwaan C. M., Ramnarain S., Bosschaart-Castermans R. M. M., Rotte A. E., Koolma A., Ammerlaan A. C. J. Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experiment Haemophilia 2016;22 (1):e1-e10 [PubMed]
• Barco S., Heuschen C. B. B. C. M., Salman B., Brekelmans M. P. A., Serlie M. J., Middeldorp S., Coppens M. Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals Journal of thrombosis and haemostasis 2016;14 (7):1364-1373 [PubMed]
• Barco Stefano, Whitney Cheung Y., Coppens Michiel, Hutten Barbara A., Meijers Joost C. M., Middeldorp Saskia In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate British journal of haematology 2016;172 (2):255-261 [PubMed]
• Barco Stefano, Serlie Mireille J., Coppens Michiel Primary thromboprophylaxis for adult patients on home parenteral nutrition: A comment on the 2016 ESPEN guideline Clinical nutrition (Edinburgh, Scotland) 2016;35 (6):1579-1580 [PubMed]
• Limperg P., Peters M., Gibbons E., Coppens M., Valk C., Grootenhuis M., Haverman L. Themes in daily life of adolescents and young adults with congenital bleeding disorders: a qualitative study Haemophilia 2016;22 (4):e330-e333 [PubMed]
• Barco Stefano Thrombosis and anticoagulant treatment in special populations 2016. 293p. ISBN 9789461826572. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Middeldorp S.; Co-supervisor: Coppens M.)

2015

• Sanders Y. V., van der Bom J. G., Isaacs A., Cnossen M. H., de Maat M. P. M., Laros-van Gorkom B. A. P., Fijnvandraat K., Meijer K., van Duijn C. M., Mauser-Bunschoten E. P., Eikenboom J., Leebeek F. W. G., Coppens M., Kors A., Nijziel M. R., Tamminga R. Y. J., Ypma P. F., Eikenboom H. C. J., Smiers F. J. W., Granzen B., Brons P. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease Journal of thrombosis and haemostasis 2015;13 (6):956-966 [PubMed]
• Coppens Michiel Contraception in women with hereditary thrombophilic defects Clinical advances in hematology & oncology 2015;13 (9):566-568 [PubMed]
• Schut A. M., Meijers J. C. M., Lisman-van Leeuwen Y., van Montfoort M. L., Roest M., de Groot P. G., Urbanus R. T., Coppens M., Lisman T. Decreased plasma levels of activated factor VII in patients with deep vein thrombosis Journal of thrombosis and haemostasis 2015;13 (7):1320-1324 [PubMed]
• Brekelmans Mpa, Middeldorp S., Coppens M. Direct factor Xa inhibitor edoxaban: from bench to clinical practice Expert review of hematology 2015;8 (6):707-725 [PubMed]
• Balvers Kirsten, Coppens Michiel, van Dieren Susan, van Rooyen-Schreurs Ingeborg H. M., Klinkspoor Henriëtte J., Zeerleder Sacha S., Baumann Holger M., Goslings J. Carel, Juffermans Nicole P. Effects of a hospital-wide introduction of a massive transfusion protocol on blood product ratio and blood product waste Journal of emergencies, trauma, and shock 2015;8 (4):199-204 [PubMed]
• Cheung Y. W., Barco S., Hutten B. A., Meijers J. C. M., Middeldorp S., Coppens M. In vivo increase in thrombin generation by four-factor prothrombin complex concentrate in apixaban-treated healthy volunteers Journal of thrombosis and haemostasis 2015;13 (10):1799-1805 [PubMed]
• Chan Noel C., Stehouwer Alexander C., Hirsh Jack, Ginsberg Jeffrey S., Alazzoni Ashraf, Coppens Michiel, Guyatt Gordon H., Eikelboom John W. Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials Thrombosis and haemostasis 2015;114 (5):1049-1057 [PubMed]
• Chan N. C., Coppens M., Hirsh J., Ginsberg J. S., Weitz J. I., Vanassche T., Douketis J. D., Schulman S., Eikelboom J. W. Real-world variability in dabigatran levels in patients with atrial fibrillation Journal of thrombosis and haemostasis 2015;13 (3):353-359 [PubMed]
• Sanders Yvonne V., Groeneveld Dafna, Meijer Karina, Fijnvandraat Karin, Cnossen Marjon H., van der Bom Johanna G., Coppens M., de Meris Joke, Laros-van Gorkom Britta A. P., Mauser-Bunschoten Eveline P., Leebeek Frank W. G., Eikenboom Jeroen, Kors A., Zweegman S., de Meris J., Goverde G. J., Jonkers M. H., Dors N., Nijziel M. R., Meijer K., Tamminga R. Y. J., van der Linden P. W., Ypma P. F., van der Bom J. G., Eikenboom J., Smiers F. J. W., Granzen B., Hamulyák K., Brons P., Laros-van Gorkom B. A. P., Cnossen M. H., Leebeek F. W. G., Sanders Y. V., Mauser-Bunschoten E. P. von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease Blood 2015;125 (19):3006-3013 [PubMed]

2014

• van Es Nick, Coppens Michiel, Schulman Sam, Middeldorp Saskia, Büller Harry R. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Blood 2014;124 (12):1968-1975 [PubMed]
• Coppens Michiel, Synhorst David, Eikelboom John W., Yusuf Salim, Shestakovska Olga, Connolly Stuart J. Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial European heart journal 2014;35 (28):1856-1863 [PubMed]
• Lauw Mandy N., Coppens Michiel, Eikelboom John W. Recent advances in antidotes for direct oral anticoagulants: their arrival is imminent Canadian journal of cardiology 2014;30 (4):381-384 [PubMed]
• Bleker Suzanne M., Coppens Michiel, Middeldorp Saskia Sex, thrombosis and inherited thrombophilia Blood reviews 2014;28 (3):123-133 [PubMed]
• Barco Stefano, Coppens Michiel, van den Dool Erik-Jan, van de Kerkhof Daan, Stroobants An K., Middeldorp Saskia Successful co-administration of dabigatran etexilate and protease inhibitors ritonavir/lopinavir in a patient with atrial fibrillation Thrombosis and haemostasis 2014;112 (4):836-838 [PubMed]

2013

• Dale Brian, Eikelboom John W., Weitz Jeffrey I., Young Ed, Paikin Jeremy S., Coppens Michiel, Whitlock Richard P., Connolly Stuart J., Ginsberg Jeffrey S., Hirsh Jack Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? Journal of thrombosis and thrombolysis 2013;35 (2):295-301 [PubMed]
• van Es Nick, Bleker Suzanne M., Büller Harry R., Coppens Michiel New developments in parenteral anticoagulation for arterial and venous thromboembolism Best practice & research. Clinical haematology 2013;26 (2):203-213 [PubMed]
• Barco Stefano, Cheung Yuk Wah, Eikelboom John W., Coppens Michiel New oral anticoagulants in elderly patients Best practice & research. Clinical haematology 2013;26 (2):215-224 [PubMed]
• Coppens M. New oral anticoagulants versus vitamin K antagonists in countries with good INR control Netherlands journal of medicine 2013;71 (4):168-169 [PubMed]
• Coppens Michiel, Hart Robert G., Eikelboom John W. Stroke prevention in older adults with atrial fibrillation CMAJ 2013;185 (17):1479-1480 [PubMed]
• Coppens Michiel, Eikelboom John W., Hart Robert G., Yusuf Salim, Lip Gregory Y. H., Dorian Paul, Shestakovska Olga, Connolly Stuart J. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy European heart journal 2013;34 (3):170-176 [PubMed]

2012

• Coppens Michiel, Eikelboom John W. Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation Circulation. Cardiovascular interventions 2012;5 (4):454-455 [PubMed]
• de Jong Paulien G., Coppens Michiel, Middeldorp Saskia Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term British journal of haematology 2012;158 (4):433-441 [PubMed]
• Lussana Federico, Coppens Michiel, Cattaneo Marco, Middeldorp Saskia Pregnancy-related venous thromboembolism: Risk and the effect of thromboprophylaxis Thrombosis research 2012;129 (6):673-680 [PubMed]
• Lauw Mandy N., Bus Erik W. N., van Wulfften Palthe Alexander F. Y., Coppens Michiel, Homburg Christa H., Middeldorp Saskia, van der Schoot C. Ellen, Koene Harry R., Biemond Bart J. Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg Annals of hematology 2012;91 (1):103-107 [PubMed]
• Coppens Michiel, Eikelboom John W., Weitz Jeffrey I. Should Warfarin Be Restarted After Warfarin-Associated Intracranial Hemorrhage? Canadian journal of cardiology 2012;28 (1):6-8 [PubMed]
• Coppens Michiel, Eikelboom John W., Gustafsson David, Weitz Jeffrey I., Hirsh Jack Translational Success Stories Development of Direct Thrombin Inhibitors Circulation research 2012;111 (7):920-929 [PubMed]

2011

• Roshani S., Lijfering W. M., Coppens M., Hamulyák K., Prins M. H., Büller H. R., Middeldorp S. Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism Netherlands journal of medicine 2011;69 (1):27-30 [PubMed]

2009

• Krekel N. M. A., Coppens M., Büller H. R., Middeldorp S. Reliability of questionnaires on the use of thromboprophylaxis Journal of thrombosis and haemostasis 2009;7 (6):1042-1043 [PubMed]
• Lijfering Willem M., Brouwer Jan-Leendert P., Veeger Nic J. G. M., Bank Ivan, Coppens Michiel, Middeldorp Saskia, Hamulyak Karly, Prins Martin H., Buller Harry R., van der Meer Jan Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives Blood 2009;113 (21):5314-5322 [PubMed]

2008

• Folkeringa Nienke, Coppens Michiel, Veeger Nic J. G. M., Bom Victor J. J., Middeldorp Saskia, Hamulyak Karly, Prins Martin H., Büller Harry R., van der Meer Jan Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels Thrombosis and haemostasis 2008;100 (1):38-44 [PubMed]
• Lijfering Willem M., Coppens Michiel, Veeger Nic J. G. M., Middeldorp Saskia, Hamulyák Karly, Prins Martin H., Büller Harry R., van der Meer Jan Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels Thrombosis research 2008;123 (2):244-250 [PubMed]
• Coppens M., Reijnders J. H., Middeldorp S., Doggen C. J. M., Rosendaal F. R. Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis Journal of thrombosis and haemostasis 2008;6 (9):1474-1477 [PubMed]
• Coppens Michiel Thrombophilia 2008. 135p. ISBN 9789090227450. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Buller Harry R.; Co-supervisor: Middeldorp S.)

2007

• Bank Ivan, van de Poel Marlène H. W., Coppens Michiel, Hamulyák Karly, Prins Martin H., van der Meer Jan, Veeger Nic J. G. M., Büller Harry R., Middeldorp Saskia Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study Thrombosis and haemostasis 2007;98 (5):1040-1044 [PubMed]
• Coppens M., van Mourik J. A., Eckmann C. M., Buller H. R., Middeldorp S. Current practise of testing for inherited thrombophilia Journal of thrombosis and haemostasis 2007;5 (9):1979-1981 [PubMed]
• Coppens M., Schreijer A. J. M., Berger F. H., Cannegieter S. C., Rosendaal F. R., Bueller H. R. Mechanical prophylaxis for travellers' thrombosis: a comparison of three interventions that promote venous outflow Journal of thrombosis and haemostasis 2007;5 (7):1556-1567 [PubMed]
• Coppens M., Folkeringa N., Teune M. J., Hamulyak K., van der Meer J., Prins M. H., Buller H. R., Middeldorp S. Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutation: reply to a rebuttal Journal of thrombosis and haemostasis 2007;5 (9):1992-1994 [PubMed]
• Coppens M., Folkeringa N., Teune M. J., Hamulyak K., van der Meer J., Prins M. H., Buller H. R., Middeldorp S. Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations Journal of thrombosis and haemostasis 2007;5 (7):1444-1448 [PubMed]
• Lijfering Willem M., Coppens Michiel, van de Poel Marlene H. W., Middeldorp Saskia, Hamulyak Karly, Bank Ivan, Veeger Nic J. G. M., Prins Martin H., Bueller Harry R., van der Meer Jan The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects Thrombosis and haemostasis 2007;98 (2):457-463 [PubMed]

2006

• Coppens Michiel, van de Poel Marlene H., Bank Ivan, Hamulyak Karly, van der Meer Jan, Veeger Nic J., Prins Martin H., Buller Harry R., Middeldorp Saskia A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation Blood 2006;108 (8):2604-2607 [PubMed]
• Coppens Michiel, Kaandorp Stef P., Middeldorp Saskia Inherited thrombophilias Obstetrics and gynecology clinics of North America 2006;33 (3):357-374 [PubMed]
• Coppens M., van Doormaal F. F., Schreijer A. J. M., Rosendaal F. R., Büller H. R. Intermittent mechanical compression for prevention of travellers' thrombosis Journal of thrombosis and haemostasis 2006;4 (8):1836-1838 [PubMed]